Abilita Bio is a biotechnology company - an alumni of JLabs San Diego - addressing enabling discovery and development of drugs targeting challenging membrane proteins, including G Protein-Coupled Receptors (GPCRs) and ion channels, including G Protein Coupled Receptors (GPCRs) and ion channels. The firm has established research collaborations with global pharmaceutical companies to advance their internal drug discovery programs targeting GPCRs and ion channels and continues to extend the EMP™ platform into new applications through multiple risk-sharing collaborations with biotechnology industry partners, while leveraging the EMP™ platform to fuel a robust internal drug discovery pipeline focused on treating cancer and chronic pain.